198 related articles for article (PubMed ID: 7247013)
1. [On the treatment of malignant hyperthermia. A simple method of preparing a dantrolene sodium solution (author's transl)].
Drechsler H
Anaesthesist; 1981 May; 30(5):257-8. PubMed ID: 7247013
[No Abstract] [Full Text] [Related]
2. Rapid intervention for an episode of malignant hyperthermia.
Chartrand D
Can J Anaesth; 2003 Feb; 50(2):104-7. PubMed ID: 12560297
[No Abstract] [Full Text] [Related]
3. Mixing and using dantrolene for simulated malignant hyperthermia crisis.
Corvetto MA; Montaña R; Bravo MP; Altermatt FR
Acta Anaesthesiol Scand; 2012 Nov; 56(10):1337-8. PubMed ID: 22881345
[No Abstract] [Full Text] [Related]
4. [An original technic for the preparation of an injectable solution of sodium dantrolene from oral capsules (Dantralen) or from the pure substance].
de Pascual Mettler I; Borrego Dionis AM; González Machado JL
Rev Esp Anestesiol Reanim; 1985; 32(4):166-8. PubMed ID: 4048581
[No Abstract] [Full Text] [Related]
5. Low-cost, easy-to-make simulated dantrolene for malignant hyperthermia scenarios.
Boet S
Acta Anaesthesiol Scand; 2014 Mar; 58(3):372-3. PubMed ID: 25237700
[No Abstract] [Full Text] [Related]
6. [Therapy of malignant hyperthermia, preliminary report].
Eberlein HJ
Anaesthesist; 1979 May; 28(5):247-8. PubMed ID: 464248
[No Abstract] [Full Text] [Related]
7. Dantrolene for malignant hyperthermia during anesthesia.
Med Lett Drugs Ther; 1980 Jul; 22(15):61-2. PubMed ID: 7393124
[No Abstract] [Full Text] [Related]
8. [Dantrolen solution of high active substance concentration. Preliminary communication (author's transl)].
Rommelsheim K; Lauven P; Westhofen P; Stenger I; Stoeckel H
Anasth Intensivther Notfallmed; 1980 Oct; 15(5):423-7. PubMed ID: 6779658
[TBL] [Abstract][Full Text] [Related]
9. [The treatment of malignant hyperthermia].
Girard JF; Funel MT; Vincent G
Cah Anesthesiol; 1990 Jan; 38(1):55-6. PubMed ID: 2357603
[No Abstract] [Full Text] [Related]
10. [Successful treatment of malignant hyperthermia with dantrolene-sodium and uneventful re-anaesthesia after oral dantrolene-prophylaxis (author's transl)].
Schulte-Sasse U; Tarnow J; Eberlein HJ
Anaesthesist; 1982 May; 31(5):241-4. PubMed ID: 6896607
[No Abstract] [Full Text] [Related]
11. [Sodium dantrolene].
Campos Suárez JM; Escolano Villén F; Catalá Puigbó E; Villar Landeira JM; Sanz Mazó M
Rev Esp Anestesiol Reanim; 1985; 32(4):179-83. PubMed ID: 3901158
[No Abstract] [Full Text] [Related]
12. [Neuroleptic malignant syndrome. Beneficial effects of dantrolene on hyperthermia and hypertonia (author's transl)].
de Rohan Chabot P; Elkharrat D; Conso F; Bismuth C; Goulon M
Nouv Presse Med; 1982 Mar; 11(14):1067-9. PubMed ID: 7079122
[No Abstract] [Full Text] [Related]
13. [Treatment of malignant hyperthermia by dantrolene sodium administered through a nasogastric tube].
Nagase M; Naganuma Y; Ryo K; Sato N; Kawashima Y
Masui; 1984 Sep; 33(9):1021-6. PubMed ID: 6512969
[No Abstract] [Full Text] [Related]
14. [Sodium dantrolene in the treatment of malignant hyperthermia].
Ording HO
Ugeskr Laeger; 1981 Sep; 143(38):2423-4. PubMed ID: 7303262
[No Abstract] [Full Text] [Related]
15. Dantrolene sodium approved for malignant hyperthermia.
FDA Drug Bull; 1979 Nov; 9(5):27. PubMed ID: 510837
[No Abstract] [Full Text] [Related]
16. [Transient normalisation of CK blood levels in patients susceptible to malignant hyperthermia by oral administration of dantrolene (author's transl)].
Bernhardt D
Anaesthesist; 1982 May; 31(5):252-4. PubMed ID: 7103034
[TBL] [Abstract][Full Text] [Related]
17. Effects of azumolene on normal and malignant hyperthermia-susceptible skeletal muscle.
Sudo RT; Carmo PL; Trachez MM; Zapata-Sudo G
Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):308-16. PubMed ID: 18047479
[TBL] [Abstract][Full Text] [Related]
18. Do we foresee new emerging drugs to treat malignant hyperthermia?
Just KS; Gerbershagen MU; Grensemann J; Wappler F
Expert Opin Emerg Drugs; 2015 Jun; 20(2):161-4. PubMed ID: 25736705
[TBL] [Abstract][Full Text] [Related]
19. Pre-anaesthetic administration of dantrolene sodium to a patient at risk from malignant hyperthermia: case report.
Free CW; Jaimon MP
N Z Med J; 1978 Dec; 88(626):493-4. PubMed ID: 283330
[TBL] [Abstract][Full Text] [Related]
20. Dantrolene and the treatment of malignant hyperthermia.
Hall GM
Br J Anaesth; 1980 Sep; 52(9):847-9. PubMed ID: 7437223
[No Abstract] [Full Text] [Related]
[Next] [New Search]
